Summary
According to APO Research, the global Endorphins market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Endorphins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Endorphins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Endorphins market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Endorphins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Endorphins market include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Egalet Corp., Endo International Plc, Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Endorphins, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Endorphins, also provides the sales of main regions and countries. Of the upcoming market potential for Endorphins, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Endorphins sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Endorphins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Endorphins sales, projected growth trends, production technology, application and end-user industry.
Endorphins Segment by Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Egalet Corp.
Endo International Plc
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Endorphins Segment by Type
Sigma-Endorphins
Gamma-Endorphins
Beta-Endorphins
Alpha-Endorphins
Endorphins Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
Endorphins Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Endorphins status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Endorphins market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Endorphins significant trends, drivers, influence factors in global and regions.
6. To analyze Endorphins competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endorphins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endorphins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endorphins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Endorphins market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endorphins industry.
Chapter 3: Detailed analysis of Endorphins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Endorphins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Endorphins in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
- Market Overview
- Product Definition
- Global Market Growth Prospects
- Global Endorphins Sales Value (2020-2031)
- Global Endorphins Sales Volume (2020-2031)
- Global Endorphins Sales Average Price (2020-2031)
- Assumptions and Limitations
- Study Goals and Objectives
- Endorphins Market Dynamics
- Endorphins Industry Trends
- Endorphins Industry Drivers
- Endorphins Industry Opportunities and Challenges
- Endorphins Industry Restraints
- Endorphins Market by Company
- Global Endorphins Company Revenue Ranking in 2024
- Global Endorphins Revenue by Company (2020-2025)
- Global Endorphins Sales Volume by Company (2020-2025)
- Global Endorphins Average Price by Company (2020-2025)
- Global Endorphins Company Ranking (2023-2025)
- Global Endorphins Company Manufacturing Base and Headquarters
- Global Endorphins Company Product Type and Application
- Global Endorphins Company Establishment Date
- Market Competitive Analysis
- Global Endorphins Market Concentration Ratio (CR5 and HHI)
- Global Top 5 and 10 Company Market Share by Revenue in 2024
- 2024 Endorphins Tier 1, Tier 2, and Tier 3 Companies
- Mergers and Acquisitions Expansion
- Endorphins Market by Type
- Endorphins Type Introduction
- Sigma-Endorphins
- Gamma-Endorphins
- Beta-Endorphins
- Alpha-Endorphins
- Global Endorphins Sales Volume by Type
- Global Endorphins Sales Volume by Type (2020 VS 2024 VS 2031)
- Global Endorphins Sales Volume by Type (2020-2031)
- Global Endorphins Sales Volume Share by Type (2020-2031)
- Global Endorphins Sales Value by Type
- Global Endorphins Sales Value by Type (2020 VS 2024 VS 2031)
- Global Endorphins Sales Value by Type (2020-2031)
- Global Endorphins Sales Value Share by Type (2020-2031)
- Endorphins Type Introduction
- Endorphins Market by Application
- Endorphins Application Introduction
- Institutional Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Endorphins Sales Volume by Application
- Global Endorphins Sales Volume by Application (2020 VS 2024 VS 2031)
- Global Endorphins Sales Volume by Application (2020-2031)
- Global Endorphins Sales Volume Share by Application (2020-2031)
- Global Endorphins Sales Value by Application
- Global Endorphins Sales Value by Application (2020 VS 2024 VS 2031)
- Global Endorphins Sales Value by Application (2020-2031)
- Global Endorphins Sales Value Share by Application (2020-2031)
- Endorphins Application Introduction
- Endorphins Regional Sales and Value Analysis
- Global Endorphins Sales by Region: 2020 VS 2024 VS 2031
- Global Endorphins Sales by Region (2020-2031)
- Global Endorphins Sales by Region: 2020-2025
- Global Endorphins Sales by Region (2026-2031)
- Global Endorphins Sales Value by Region: 2020 VS 2024 VS 2031
- Global Endorphins Sales Value by Region (2020-2031)
- Global Endorphins Sales Value by Region: 2020-2025
- Global Endorphins Sales Value by Region (2026-2031)
- Global Endorphins Market Price Analysis by Region (2020-2025)
- North America
- North America Endorphins Sales Value (2020-2031)
- North America Endorphins Sales Value Share by Country, 2024 VS 2031
- Europe
- Europe Endorphins Sales Value (2020-2031)
- Europe Endorphins Sales Value Share by Country, 2024 VS 2031
- Asia-Pacific
- Asia-Pacific Endorphins Sales Value (2020-2031)
- Asia-Pacific Endorphins Sales Value Share by Country, 2024 VS 2031
- South America
- South America Endorphins Sales Value (2020-2031)
- South America Endorphins Sales Value Share by Country, 2024 VS 2031
- Middle East & Africa
- Middle East & Africa Endorphins Sales Value (2020-2031)
- Middle East & Africa Endorphins Sales Value Share by Country, 2024 VS 2031
- Endorphins Country-level Sales and Value Analysis
- Global Endorphins Sales by Country: 2020 VS 2024 VS 2031
- Global Endorphins Sales Value by Country: 2020 VS 2024 VS 2031
- Global Endorphins Sales by Country (2020-2031)
- Global Endorphins Sales by Country (2020-2025)
- Global Endorphins Sales by Country (2026-2031)
- Global Endorphins Sales Value by Country (2020-2031)
- Global Endorphins Sales Value by Country (2020-2025)
- Global Endorphins Sales Value by Country (2026-2031)
- USA
- USA Endorphins Sales Value Growth Rate (2020-2031)
- USA Endorphins Sales Value Share by Type, 2024 VS 2031
- USA Endorphins Sales Value Share by Application, 2024 VS 2031
- Canada
- Canada Endorphins Sales Value Growth Rate (2020-2031)
- Canada Endorphins Sales Value Share by Type, 2024 VS 2031
- Canada Endorphins Sales Value Share by Application, 2024 VS 2031
- Mexico
- Mexico Endorphins Sales Value Growth Rate (2020-2031)
- Mexico Endorphins Sales Value Share by Type, 2024 VS 2031
- Mexico Endorphins Sales Value Share by Application, 2024 VS 2031
- Germany
- Germany Endorphins Sales Value Growth Rate (2020-2031)
- Germany Endorphins Sales Value Share by Type, 2024 VS 2031
- Germany Endorphins Sales Value Share by Application, 2024 VS 2031
- France
- France Endorphins Sales Value Growth Rate (2020-2031)
- France Endorphins Sales Value Share by Type, 2024 VS 2031
- France Endorphins Sales Value Share by Application, 2024 VS 2031
- U.K.
- U.K. Endorphins Sales Value Growth Rate (2020-2031)
- U.K. Endorphins Sales Value Share by Type, 2024 VS 2031
- U.K. Endorphins Sales Value Share by Application, 2024 VS 2031
- Italy
- Italy Endorphins Sales Value Growth Rate (2020-2031)
- Italy Endorphins Sales Value Share by Type, 2024 VS 2031
- Italy Endorphins Sales Value Share by Application, 2024 VS 2031
- Spain
- Spain Endorphins Sales Value Growth Rate (2020-2031)
- Spain Endorphins Sales Value Share by Type, 2024 VS 2031
- Spain Endorphins Sales Value Share by Application, 2024 VS 2031
- Russia
- Russia Endorphins Sales Value Growth Rate (2020-2031)
- Russia Endorphins Sales Value Share by Type, 2024 VS 2031
- Russia Endorphins Sales Value Share by Application, 2024 VS 2031
- Netherlands
- Netherlands Endorphins Sales Value Growth Rate (2020-2031)
- Netherlands Endorphins Sales Value Share by Type, 2024 VS 2031
- Netherlands Endorphins Sales Value Share by Application, 2024 VS 2031
- Nordic Countries
- Nordic Countries Endorphins Sales Value Growth Rate (2020-2031)
- Nordic Countries Endorphins Sales Value Share by Type, 2024 VS 2031
- Nordic Countries Endorphins Sales Value Share by Application, 2024 VS 2031
- China
- China Endorphins Sales Value Growth Rate (2020-2031)
- China Endorphins Sales Value Share by Type, 2024 VS 2031
- China Endorphins Sales Value Share by Application, 2024 VS 2031
- Japan
- Japan Endorphins Sales Value Growth Rate (2020-2031)
- Japan Endorphins Sales Value Share by Type, 2024 VS 2031
- Japan Endorphins Sales Value Share by Application, 2024 VS 2031
- South Korea
- South Korea Endorphins Sales Value Growth Rate (2020-2031)
- South Korea Endorphins Sales Value Share by Type, 2024 VS 2031
- South Korea Endorphins Sales Value Share by Application, 2024 VS 2031
- India
- India Endorphins Sales Value Growth Rate (2020-2031)
- India Endorphins Sales Value Share by Type, 2024 VS 2031
- India Endorphins Sales Value Share by Application, 2024 VS 2031
- Australia
- Australia Endorphins Sales Value Growth Rate (2020-2031)
- Australia Endorphins Sales Value Share by Type, 2024 VS 2031
- Australia Endorphins Sales Value Share by Application, 2024 VS 2031
- Southeast Asia
- Southeast Asia Endorphins Sales Value Growth Rate (2020-2031)
- Southeast Asia Endorphins Sales Value Share by Type, 2024 VS 2031
- Southeast Asia Endorphins Sales Value Share by Application, 2024 VS 2031
- Brazil
- Brazil Endorphins Sales Value Growth Rate (2020-2031)
- Brazil Endorphins Sales Value Share by Type, 2024 VS 2031
- Brazil Endorphins Sales Value Share by Application, 2024 VS 2031
- Argentina
- Argentina Endorphins Sales Value Growth Rate (2020-2031)
- Argentina Endorphins Sales Value Share by Type, 2024 VS 2031
- Argentina Endorphins Sales Value Share by Application, 2024 VS 2031
- Chile
- Chile Endorphins Sales Value Growth Rate (2020-2031)
- Chile Endorphins Sales Value Share by Type, 2024 VS 2031
- Chile Endorphins Sales Value Share by Application, 2024 VS 2031
- Colombia
- Colombia Endorphins Sales Value Growth Rate (2020-2031)
- Colombia Endorphins Sales Value Share by Type, 2024 VS 2031
- Colombia Endorphins Sales Value Share by Application, 2024 VS 2031
- Peru
- Peru Endorphins Sales Value Growth Rate (2020-2031)
- Peru Endorphins Sales Value Share by Type, 2024 VS 2031
- Peru Endorphins Sales Value Share by Application, 2024 VS 2031
- Saudi Arabia
- Saudi Arabia Endorphins Sales Value Growth Rate (2020-2031)
- Saudi Arabia Endorphins Sales Value Share by Type, 2024 VS 2031
- Saudi Arabia Endorphins Sales Value Share by Application, 2024 VS 2031
- Israel
- Israel Endorphins Sales Value Growth Rate (2020-2031)
- Israel Endorphins Sales Value Share by Type, 2024 VS 2031
- Israel Endorphins Sales Value Share by Application, 2024 VS 2031
- UAE
- UAE Endorphins Sales Value Growth Rate (2020-2031)
- UAE Endorphins Sales Value Share by Type, 2024 VS 2031
- UAE Endorphins Sales Value Share by Application, 2024 VS 2031
- Turkey
- Turkey Endorphins Sales Value Growth Rate (2020-2031)
- Turkey Endorphins Sales Value Share by Type, 2024 VS 2031
- Turkey Endorphins Sales Value Share by Application, 2024 VS 2031
- Iran
- Iran Endorphins Sales Value Growth Rate (2020-2031)
- Iran Endorphins Sales Value Share by Type, 2024 VS 2031
- Iran Endorphins Sales Value Share by Application, 2024 VS 2031
- Egypt
- Egypt Endorphins Sales Value Growth Rate (2020-2031)
- Egypt Endorphins Sales Value Share by Type, 2024 VS 2031
- Egypt Endorphins Sales Value Share by Application, 2024 VS 2031
- Company Profiles
- Assertio Therapeutics Inc.
- Assertio Therapeutics Inc. Comapny Information
- Assertio Therapeutics Inc. Business Overview
- Assertio Therapeutics Inc. Endorphins Sales, Value and Gross Margin (2020-2025)
- Assertio Therapeutics Inc. Endorphins Product Portfolio
- Assertio Therapeutics Inc. Recent Developments
- Cipher Pharmaceuticals Inc.
- Cipher Pharmaceuticals Inc. Comapny Information
- Cipher Pharmaceuticals Inc. Business Overview
- Cipher Pharmaceuticals Inc. Endorphins Sales, Value and Gross Margin (2020-2025)
- Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
- Cipher Pharmaceuticals Inc. Recent Developments
- Egalet Corp.
- Egalet Corp. Comapny Information
- Egalet Corp. Business Overview
- Egalet Corp. Endorphins Sales, Value and Gross Margin (2020-2025)
- Egalet Corp. Endorphins Product Portfolio
- Egalet Corp. Recent Developments
- Endo International Plc
- Endo International Plc Comapny Information
- Endo International Plc Business Overview
- Endo International Plc Endorphins Sales, Value and Gross Margin (2020-2025)
- Endo International Plc Endorphins Product Portfolio
- Endo International Plc Recent Developments
- Lannett Co. Inc.
- Lannett Co. Inc. Comapny Information
- Lannett Co. Inc. Business Overview
- Lannett Co. Inc. Endorphins Sales, Value and Gross Margin (2020-2025)
- Lannett Co. Inc. Endorphins Product Portfolio
- Lannett Co. Inc. Recent Developments
- Pfizer
- Pfizer Comapny Information
- Pfizer Business Overview
- Pfizer Endorphins Sales, Value and Gross Margin (2020-2025)
- Pfizer Endorphins Product Portfolio
- Pfizer Recent Developments
- Johnson & Johnson
- Johnson & Johnson Comapny Information
- Johnson & Johnson Business Overview
- Johnson & Johnson Endorphins Sales, Value and Gross Margin (2020-2025)
- Johnson & Johnson Endorphins Product Portfolio
- Johnson & Johnson Recent Developments
- Assertio Therapeutics Inc.
- Value Chain and Sales Channels Analysis
- Endorphins Value Chain Analysis
- Endorphins Key Raw Materials
- Raw Materials Key Suppliers
- Manufacturing Cost Structure
- Endorphins Sales Mode & Process
- Endorphins Sales Channels Analysis
- Direct Comparison with Distribution Share
- Endorphins Distributors
- Endorphins Customers
- Endorphins Value Chain Analysis
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
List of Tables
Table 1 | :Endorphins Industry Trends |
Table 2 | :Endorphins Industry Drivers |
Table 3 | :Endorphins Industry Opportunities and Challenges |
Table 4 | :Endorphins Industry Restraints |
Table 5 | :Global Endorphins Revenue by Company (US$ Million) & (2020-2025) |
Table 6 | :Global Endorphins Revenue Share by Company (2020-2025) |
Table 7 | :Global Endorphins Sales Volume by Company (K Units) & (2020-2025) |
Table 8 | :Global Endorphins Sales Volume Share by Company (2020-2025) |
Table 9 | :Global Endorphins Average Price (US$/Unit) of Company (2020-2025) |
Table 10 | :Global Endorphins Company Ranking, (2023-2025) & (USD Million) |
Table 11 | :Global Endorphins Key Company Manufacturing Base & Headquarters |
Table 12 | :Global Endorphins Company, Product Type & Application |
Table 13 | :Global Endorphins Company Establishment Date |
Table 14 | :Global Company Market Concentration Ratio (CR5 and HHI) |
Table 15 | :Global Endorphins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2024) |
Table 16 | :Mergers & Acquisitions, Expansion |
Table 17 | :Significant Companies of Sigma-Endorphins |
Table 18 | :Significant Companies of Gamma-Endorphins |
Table 19 | :Significant Companies of Beta-Endorphins |
Table 20 | :Significant Companies of Alpha-Endorphins |
Table 21 | :Global Endorphins Sales Volume by Type 2020 VS 2024 VS 2031 (K Units) |
Table 22 | :Global Endorphins Sales Volume by Type (2020-2025) & (K Units) |
Table 23 | :Global Endorphins Sales Volume by Type (2026-2031) & (K Units) |
Table 24 | :Global Endorphins Sales Volume Share by Type (2020-2025) |
Table 25 | :Global Endorphins Sales Volume Share by Type (2026-2031) |
Table 26 | :Global Endorphins Sales Value by Type 2020 VS 2024 VS 2031 (US$ Million) |
Table 27 | :Global Endorphins Sales Value by Type (2020-2025) & (US$ Million) |
Table 28 | :Global Endorphins Sales Value by Type (2026-2031) & (US$ Million) |
Table 29 | :Global Endorphins Sales Value Share by Type (2020-2025) |
Table 30 | :Global Endorphins Sales Value Share by Type (2026-2031) |
Table 31 | :Significant Companies of Institutional Pharmacies |
Table 32 | :Significant Companies of Retail Pharmacies |
Table 33 | :Significant Companies of Online Pharmacies |
Table 34 | :Global Endorphins Sales Volume by Application 2020 VS 2024 VS 2031 (K Units) |
Table 35 | :Global Endorphins Sales Volume by Application (2020-2025) & (K Units) |
Table 36 | :Global Endorphins Sales Volume by Application (2026-2031) & (K Units) |
Table 37 | :Global Endorphins Sales Volume Share by Application (2020-2025) |
Table 38 | :Global Endorphins Sales Volume Share by Application (2026-2031) |
Table 39 | :Global Endorphins Sales Value by Application 2020 VS 2024 VS 2031 (US$ Million) |
Table 40 | :Global Endorphins Sales Value by Application (2020-2025) & (US$ Million) |
Table 41 | :Global Endorphins Sales Value by Application (2026-2031) & (US$ Million) |
Table 42 | :Global Endorphins Sales Value Share by Application (2020-2025) |
Table 43 | :Global Endorphins Sales Value Share by Application (2026-2031) |
Table 44 | :Global Endorphins Sales by Region: 2020 VS 2024 VS 2031 (K Units) |
Table 45 | :Global Endorphins Sales by Region (2020-2025) & (K Units) |
Table 46 | :Global Endorphins Sales Market Share by Region (2020-2025) |
Table 47 | :Global Endorphins Sales by Region (2026-2031) & (K Units) |
Table 48 | :Global Endorphins Sales Market Share by Region (2026-2031) |
Table 49 | :Global Endorphins Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Table 50 | :Global Endorphins Sales Value by Region (2020-2025) & (US$ Million) |
Table 51 | :Global Endorphins Sales Value Share by Region (2020-2025) |
Table 52 | :Global Endorphins Sales Value by Region (2026-2031) & (US$ Million) |
Table 53 | :Global Endorphins Sales Value Share by Region (2026-2031) |
Table 54 | :Global Endorphins Market Average Price (US$/Unit) by Region (2020-2025) |
Table 55 | :Global Endorphins Market Average Price (US$/Unit) by Region (2026-2031) |
Table 56 | :Global Endorphins Sales by Country: 2020 VS 2024 VS 2031 (K Units) |
Table 57 | :Global Endorphins Sales Value by Country: 2020 VS 2024 VS 2031 (US$ Million) |
Table 58 | :Global Endorphins Sales by Country (2020-2025) & (K Units) |
Table 59 | :Global Endorphins Sales Market Share by Country (2020-2025) |
Table 60 | :Global Endorphins Sales by Country (2026-2031) & (K Units) |
Table 61 | :Global Endorphins Sales Market Share by Country (2026-2031) |
Table 62 | :Global Endorphins Sales Value by Country (2020-2025) & (US$ Million) |
Table 63 | :Global Endorphins Sales Value Market Share by Country (2020-2025) |
Table 64 | :Global Endorphins Sales Value by Country (2026-2031) & (US$ Million) |
Table 65 | :Global Endorphins Sales Value Market Share by Country (2026-2031) |
Table 66 | :Assertio Therapeutics Inc. Company Information |
Table 67 | :Assertio Therapeutics Inc. Business Overview |
Table 68 | :Assertio Therapeutics Inc. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 69 | :Assertio Therapeutics Inc. Endorphins Product Portfolio |
Table 70 | :Assertio Therapeutics Inc. Recent Development |
Table 71 | :Cipher Pharmaceuticals Inc. Company Information |
Table 72 | :Cipher Pharmaceuticals Inc. Business Overview |
Table 73 | :Cipher Pharmaceuticals Inc. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 74 | :Cipher Pharmaceuticals Inc. Endorphins Product Portfolio |
Table 75 | :Cipher Pharmaceuticals Inc. Recent Development |
Table 76 | :Egalet Corp. Company Information |
Table 77 | :Egalet Corp. Business Overview |
Table 78 | :Egalet Corp. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 79 | :Egalet Corp. Endorphins Product Portfolio |
Table 80 | :Egalet Corp. Recent Development |
Table 81 | :Endo International Plc Company Information |
Table 82 | :Endo International Plc Business Overview |
Table 83 | :Endo International Plc Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 84 | :Endo International Plc Endorphins Product Portfolio |
Table 85 | :Endo International Plc Recent Development |
Table 86 | :Lannett Co. Inc. Company Information |
Table 87 | :Lannett Co. Inc. Business Overview |
Table 88 | :Lannett Co. Inc. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 89 | :Lannett Co. Inc. Endorphins Product Portfolio |
Table 90 | :Lannett Co. Inc. Recent Development |
Table 91 | :Pfizer Company Information |
Table 92 | :Pfizer Business Overview |
Table 93 | :Pfizer Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 94 | :Pfizer Endorphins Product Portfolio |
Table 95 | :Pfizer Recent Development |
Table 96 | :Johnson & Johnson Company Information |
Table 97 | :Johnson & Johnson Business Overview |
Table 98 | :Johnson & Johnson Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025) |
Table 99 | :Johnson & Johnson Endorphins Product Portfolio |
Table 100 | :Johnson & Johnson Recent Development |
Table 101 | :Key Raw Materials |
Table 102 | :Raw Materials Key Suppliers |
Table 103 | :Endorphins Distributors List |
Table 104 | :Endorphins Customers List |
Table 105 | :Research Programs/Design for This Report |
Table 106 | :Authors List of This Report |
Table 107 | :Secondary Sources |
Table 108 | :Primary Sources |
List of Figures
Figure 1 | :Endorphins Product Image |
Figure 2 | :Global Endorphins Sales Value (US$ Million), 2020 VS 2024 VS 2031 |
Figure 3 | :Global Endorphins Sales Value (2020-2031) & (US$ Million) |
Figure 4 | :Global Endorphins Sales (2020-2031) & (K Units) |
Figure 5 | :Global Endorphins Sales Average Price (US$/Unit) & (2020-2031) |
Figure 6 | :Global Endorphins Company Revenue Ranking in 2024 (US$ Million) |
Figure 7 | :Global Top 5 and 10 Company Market Share by Revenue in 2024 (US$ Million) |
Figure 8 | :Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024 |
Figure 9 | :Sigma-Endorphins Image |
Figure 10 | :Gamma-Endorphins Image |
Figure 11 | :Beta-Endorphins Image |
Figure 12 | :Alpha-Endorphins Image |
Figure 13 | :Global Endorphins Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units) |
Figure 14 | :Global Endorphins Sales Volume Share 2020 VS 2024 VS 2031 |
Figure 15 | :Global Endorphins Sales Volume Share by Type (2020-2031) |
Figure 16 | :Global Endorphins Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 17 | :Global Endorphins Sales Value Share 2020 VS 2024 VS 2031 |
Figure 18 | :Global Endorphins Sales Value Share by Type (2020-2031) |
Figure 19 | :Institutional Pharmacies Image |
Figure 20 | :Retail Pharmacies Image |
Figure 21 | :Online Pharmacies Image |
Figure 22 | :Global Endorphins Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units) |
Figure 23 | :Global Endorphins Sales Volume Share 2020 VS 2024 VS 2031 |
Figure 24 | :Global Endorphins Sales Volume Share by Application (2020-2031) |
Figure 25 | :Global Endorphins Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 26 | :Global Endorphins Sales Value Share 2020 VS 2024 VS 2031 |
Figure 27 | :Global Endorphins Sales Value Share by Application (2020-2031) |
Figure 28 | :Global Endorphins Sales by Region: 2020 VS 2024 VS 2031 (K Units) |
Figure 29 | :Global Endorphins Sales Market Share by Region: 2020 VS 2024 VS 2031 |
Figure 30 | :Global Endorphins Sales Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Figure 31 | :Global Endorphins Sales Value Share by Region: 2020 VS 2024 VS 2031 |
Figure 32 | :North America Endorphins Sales Value (2020-2031) & (US$ Million) |
Figure 33 | :North America Endorphins Sales Value Share by Country (%), 2024 VS 2031 |
Figure 34 | :Europe Endorphins Sales Value (2020-2031) & (US$ Million) |
Figure 35 | :Europe Endorphins Sales Value Share by Country (%), 2024 VS 2031 |
Figure 36 | :Asia-Pacific Endorphins Sales Value (2020-2031) & (US$ Million) |
Figure 37 | :Asia-Pacific Endorphins Sales Value Share by Country (%), 2024 VS 2031 |
Figure 38 | :South America Endorphins Sales Value (2020-2031) & (US$ Million) |
Figure 39 | :South America Endorphins Sales Value Share by Country (%), 2024 VS 2031 |
Figure 40 | :Middle East & Africa Endorphins Sales Value (2020-2031) & (US$ Million) |
Figure 41 | :Middle East & Africa Endorphins Sales Value Share by Country (%), 2024 VS 2031 |
Figure 42 | :USA Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 43 | :USA Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 44 | :USA Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 45 | :Canada Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 46 | :Canada Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 47 | :Canada Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 48 | :Mexico Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 49 | :Mexico Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 50 | :Mexico Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 51 | :Germany Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 52 | :Germany Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 53 | :Germany Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 54 | :France Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 55 | :France Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 56 | :France Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 57 | :U.K. Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 58 | :U.K. Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 59 | :U.K. Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 60 | :Italy Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 61 | :Italy Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 62 | :Italy Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 63 | :Spain Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 64 | :Spain Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 65 | :Spain Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 66 | :Russia Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 67 | :Russia Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 68 | :Russia Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 69 | :Netherlands Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 70 | :Netherlands Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 71 | :Netherlands Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 72 | :Nordic Countries Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 73 | :Nordic Countries Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 74 | :Nordic Countries Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 75 | :China Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 76 | :China Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 77 | :China Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 78 | :Japan Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 79 | :Japan Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 80 | :Japan Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 81 | :South Korea Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 82 | :South Korea Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 83 | :South Korea Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 84 | :India Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 85 | :India Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 86 | :India Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 87 | :Australia Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 88 | :Australia Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 89 | :Australia Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 90 | :Southeast Asia Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 91 | :Southeast Asia Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 92 | :Southeast Asia Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 93 | :Brazil Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 94 | :Brazil Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 95 | :Brazil Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 96 | :Argentina Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 97 | :Argentina Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 98 | :Argentina Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 99 | :Chile Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 100 | :Chile Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 101 | :Chile Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 102 | :Colombia Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 103 | :Colombia Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 104 | :Colombia Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 105 | :Peru Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 106 | :Peru Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 107 | :Peru Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 108 | :Saudi Arabia Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 109 | :Saudi Arabia Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 110 | :Saudi Arabia Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 111 | :Israel Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 112 | :Israel Arabia Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 113 | :Israel Arabia Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 114 | :UAE Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 115 | :UAE Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 116 | :UAE Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 117 | :Turkey Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 118 | :Turkey Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 119 | :Turkey Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 120 | :Iran Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 121 | :Iran Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 122 | :Iran Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 123 | :Egypt Endorphins Sales Value Growth Rate (2020-2031) & (US$ Million) |
Figure 124 | :Egypt Endorphins Sales Value Share by Type, 2024 VS 2031 & (%) |
Figure 125 | :Egypt Endorphins Sales Value Share by Application, 2024 VS 2031 & (%) |
Figure 126 | :Endorphins Value Chain |
Figure 127 | :Manufacturing Cost Structure |
Figure 128 | :Endorphins Sales Mode & Process |
Figure 129 | :Direct Comparison with Distribution Share |
Figure 130 | :Distributors Profiles |
Figure 131 | :Years Considered |
Figure 132 | :Research Process |
Figure 133 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Pharma & Healthcare
Global Endorphins Market Outlook and Growth Opportunities 2025
Pages: 198
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.